Cargando…
An Empirical Study on the Equity Performance of China's Health Insurance Companies During the COVID-19 Pandemic—Based on Cases of Dominant Listed Companies
The health insurance industry in China is undergoing great shocks and profound impacts induced by the worldwide COVID-19 pandemic. Taking for instance the three dominant listed companies, namely, China Life Insurance, Ping An Insurance, and Pacific Insurance, this paper investigates the equity perfo...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141801/ https://www.ncbi.nlm.nih.gov/pubmed/34041217 http://dx.doi.org/10.3389/fpubh.2021.663189 |
_version_ | 1783696442735460352 |
---|---|
author | Ye, Rendao An, Na Xie, Yichen Luo, Kun Lin, Ya |
author_facet | Ye, Rendao An, Na Xie, Yichen Luo, Kun Lin, Ya |
author_sort | Ye, Rendao |
collection | PubMed |
description | The health insurance industry in China is undergoing great shocks and profound impacts induced by the worldwide COVID-19 pandemic. Taking for instance the three dominant listed companies, namely, China Life Insurance, Ping An Insurance, and Pacific Insurance, this paper investigates the equity performances of China's health insurance companies during the pandemic. We firstly construct a stock price forecasting methodology using the autoregressive integrated moving average, back propagation neural network, and long short-term memory (LSTM) neural network models. We then empirically study the stock price performances of the three listed companies and find out that the LSTM model does better than the other two based on the criteria of mean absolute error and mean square error. Finally, the above-mentioned models are used to predict the stock price performances of the three companies. |
format | Online Article Text |
id | pubmed-8141801 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81418012021-05-25 An Empirical Study on the Equity Performance of China's Health Insurance Companies During the COVID-19 Pandemic—Based on Cases of Dominant Listed Companies Ye, Rendao An, Na Xie, Yichen Luo, Kun Lin, Ya Front Public Health Public Health The health insurance industry in China is undergoing great shocks and profound impacts induced by the worldwide COVID-19 pandemic. Taking for instance the three dominant listed companies, namely, China Life Insurance, Ping An Insurance, and Pacific Insurance, this paper investigates the equity performances of China's health insurance companies during the pandemic. We firstly construct a stock price forecasting methodology using the autoregressive integrated moving average, back propagation neural network, and long short-term memory (LSTM) neural network models. We then empirically study the stock price performances of the three listed companies and find out that the LSTM model does better than the other two based on the criteria of mean absolute error and mean square error. Finally, the above-mentioned models are used to predict the stock price performances of the three companies. Frontiers Media S.A. 2021-05-10 /pmc/articles/PMC8141801/ /pubmed/34041217 http://dx.doi.org/10.3389/fpubh.2021.663189 Text en Copyright © 2021 Ye, An, Xie, Luo and Lin. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Public Health Ye, Rendao An, Na Xie, Yichen Luo, Kun Lin, Ya An Empirical Study on the Equity Performance of China's Health Insurance Companies During the COVID-19 Pandemic—Based on Cases of Dominant Listed Companies |
title | An Empirical Study on the Equity Performance of China's Health Insurance Companies During the COVID-19 Pandemic—Based on Cases of Dominant Listed Companies |
title_full | An Empirical Study on the Equity Performance of China's Health Insurance Companies During the COVID-19 Pandemic—Based on Cases of Dominant Listed Companies |
title_fullStr | An Empirical Study on the Equity Performance of China's Health Insurance Companies During the COVID-19 Pandemic—Based on Cases of Dominant Listed Companies |
title_full_unstemmed | An Empirical Study on the Equity Performance of China's Health Insurance Companies During the COVID-19 Pandemic—Based on Cases of Dominant Listed Companies |
title_short | An Empirical Study on the Equity Performance of China's Health Insurance Companies During the COVID-19 Pandemic—Based on Cases of Dominant Listed Companies |
title_sort | empirical study on the equity performance of china's health insurance companies during the covid-19 pandemic—based on cases of dominant listed companies |
topic | Public Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141801/ https://www.ncbi.nlm.nih.gov/pubmed/34041217 http://dx.doi.org/10.3389/fpubh.2021.663189 |
work_keys_str_mv | AT yerendao anempiricalstudyontheequityperformanceofchinashealthinsurancecompaniesduringthecovid19pandemicbasedoncasesofdominantlistedcompanies AT anna anempiricalstudyontheequityperformanceofchinashealthinsurancecompaniesduringthecovid19pandemicbasedoncasesofdominantlistedcompanies AT xieyichen anempiricalstudyontheequityperformanceofchinashealthinsurancecompaniesduringthecovid19pandemicbasedoncasesofdominantlistedcompanies AT luokun anempiricalstudyontheequityperformanceofchinashealthinsurancecompaniesduringthecovid19pandemicbasedoncasesofdominantlistedcompanies AT linya anempiricalstudyontheequityperformanceofchinashealthinsurancecompaniesduringthecovid19pandemicbasedoncasesofdominantlistedcompanies AT yerendao empiricalstudyontheequityperformanceofchinashealthinsurancecompaniesduringthecovid19pandemicbasedoncasesofdominantlistedcompanies AT anna empiricalstudyontheequityperformanceofchinashealthinsurancecompaniesduringthecovid19pandemicbasedoncasesofdominantlistedcompanies AT xieyichen empiricalstudyontheequityperformanceofchinashealthinsurancecompaniesduringthecovid19pandemicbasedoncasesofdominantlistedcompanies AT luokun empiricalstudyontheequityperformanceofchinashealthinsurancecompaniesduringthecovid19pandemicbasedoncasesofdominantlistedcompanies AT linya empiricalstudyontheequityperformanceofchinashealthinsurancecompaniesduringthecovid19pandemicbasedoncasesofdominantlistedcompanies |